Iron Therapy in Patients With End-Stage Renal Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anemia
- Cardiovascular Risk Factor
- End Stage Renal Disease
- Inflammation
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 99 years
- Gender
- Both males and females
Description
After two years of treatments, we will compare the incidence of clinical events, monthly blood, and biochemical examination data for the two years before and after the change.
After two years of treatments, we will compare the incidence of clinical events, monthly blood, and biochemical examination data for the two years before and after the change.
Tracking Information
- NCT #
- NCT04491916
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Hugo Y Lin, MD,PhD Kaohsiung Medical University Principal Investigator: Hugo Y Lin, MD,PhD Kaohsiung Municipal Ta-Tung Hospital
Get Well Soon